1AI 0.00% 0.7¢ algorae pharmaceuticals limited

Ann: Appendix 4C - quarterly, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 15,654 Posts.
    lightbulb Created with Sketch. 5717
    Been doing a bit of sniffing around Quarterly Reports today.... and some things I noticed:

    Receipts from customers has increased by 74.5% from $26,862 in March 2018 quarter to $46,350 in June 2018 quarter. YOY is over 11% increase in 'receipts from customers'.... so that is a positive.

    Estimated cash outflows for September quarter is flagged to increase to $1,339,187 ($1,033,349 after $305,838 anticipated Government Grant receipts) which includes a $250,000 + increase in R&D spending. (was mentioned when quarterly came out but I thought it worth noting again). This total anticipated seems high in comparison to the entire annual spend in 2017/2018 FY of $3,674,371 * ?

    Let's hope that there is something good to come out of this quarter folks

    *This figure is after receipts/grants have been taken into consideration
    Last edited by col69: 01/08/18
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.000(0.00%)
Mkt cap ! $11.81M
Open High Low Value Volume
0.7¢ 0.8¢ 0.7¢ $21.44K 3.049M

Buyers (Bids)

No. Vol. Price($)
16 6215793 0.6¢
 

Sellers (Offers)

Price($) Vol. No.
0.7¢ 552894 2
View Market Depth
Last trade - 15.38pm 02/10/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.